Perilesional neurochemical changes in focal epilepsies.
Circumscribed cortical lesions are frequently encountered in patients with chronic focal epilepsies. However, the pathogenesis of seizures is poorly understood. To determine whether the perilesional cortex shows evidence for abnormal excitatory or inhibitory neurochemical activity, we immunohistochemically examined the distribution of the alpha 1 subunit of the GABAA receptor (GABAR), the N-methyl-D-aspartate receptor subunit 1 (NR1), and glutamate decarboxylase (GAD) in 30 surgical specimens of neocortical epilepsy-associated lesions. These comprised 7 low-grade gliomas, 2 gangliogliomas, 2 dysembryoplastic neuroepithelial tumors, 4 glioneuronal malformations, 5 vascular malformations, and 10 glial or gliomesodermal scars. All specimens originated from patients with chronic pharmacoresistant epilepsy. In 73% of the cases there was a distinct difference in immunoreactivity for GABAR, GAD or NR1 between the perilesional zone and the normal cortex. With each of the markers there was reduced perilesional immunoreactivity in 30% of the specimens. Increased staining of GAD was seen in 17%, for GABAR in 7%, and for NR1 in 13% of the cases. The age at surgery, onset of seizures, epilepsy duration, and maximal seizure frequency did not differ significantly between patients with normal and those with altered perilesional immunoreactivity patterns. Although the perilesional changes for GAD, GABAR or NR1 were heterogeneous, they suggest a disturbed balance between excitatory and inhibitory synaptic transmission which may contribute to the pathogenesis of focal seizures.
Wolf
H K
HK
Department of Neuropathology, University of Bonn Medical Center, Germany.
Roos
D
D
Blümcke
I
I
Pietsch
T
T
Wiestler
O D
OD
D004828:Epilepsies, Partial / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D018377:Neurotransmitter Agents / Q000032:analysis*; D018079:Receptors, GABA / Q000032:analysis
D018377:Neurotransmitter Agents; D018079:Receptors, GABA